Trends in non-receipt of recommended COPD medication

Abstract

This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online.

Guideline-discordant inhaler regimens after COPD hospitalization: associations with rurality, drive time to care, and fragmented care – a United States cohort study

“…found that only 12% received guideline-discordant inhaler regimens (defined as not receiving LAMA or ICS + LABA) among patients hospitalized for COPD exacerbation or patients with ≥2 COPD exacerbations in Ontario, Canada. 12 , 42 Among COPD patients discharged from hospitals in Italy, Di Martino et al. reported that 35% received guideline-discordant inhaler prescriptions, defined as not receiving LAMA or LABA.…”